Can Whole Exome Sequencing Explain Prenatal Loss With Insufficient Fetal DNA?
BACKGROUND AND PURPOSE:
Whole exome sequencing (WES) can diagnose 25 to 37% of postnatal unexplained single gene disorders
The technique depends on obtaining good quality DNA from ‘trios’ – mother/father/affected child
In the prenatal setting, identification of lethal prenatal genetic disorders is not always possible using the ‘trio’ approach, due to either poor quality or insufficient quantity of fetal DNA
Stals et al. (Prenatal Diagnosis, 2017) have developed a novel technique to detect recessive single gene disorders using parental samples and saving fetal DNA where available for confirmation studies
WES sequencing was performed on couples (unaffected) with at least 1 fetus affected with severe, lethal, prenatal onset disease
Special filtering was applied to WES data
Fetal DNA was saved to confirm pathogenic variants
Potential pathogenic variants were identified using a bioinformatics pipeline that highlighted changes in disease-causing genes consistent with the clinical phenotype and autosomal recessive inheritance pattern
Disease-causing variants were confirmed using stored fetal DNA
Exome sequencing was carried out in a consecutive series of 50 couples
WES identified heterozygous pathogenic (or likely pathogenic) variants in 24 different genes in 26/50 couples (52%)
A genetic diagnosis was obtained in 18/29 cases (62%) when 2 fetuses in a family were affected and in 8/21 (38%) when only 1 fetus was affected
In 25 cases, autosomal recessive inheritance was identified and in 1 case, an X-linked recessive disorder was identified
A diagnosis was made in 6/11 (54%) of couples who were consanguineous
Exome sequencing of parental samples is a powerful strategy for diagnosing lethal or prenatal-onset recessive disorders and can be applied even in the absence of large, high quality fetal samples
The authors suggest various explanations for those cases that remained undiagnosed including
Disorder may not yet be associated with a known phenotype
Disorder may not be a monogenic (single gene), autosomal recessive disorder
Identifying pathogenic variants may provide useful information to parents considering PGD or prenatal diagnosis in subsequent pregnancies
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan